The combined effects of menopause and dietary glucosamine on the development of insulin resistance

Menopause

Volumn 19, Issue 5, 2012, Pages 487-488

  Pru, James K ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; GLUCOSAMINE; GLUCOSE; GLUCOSE TRANSPORTER 4; HEXOSAMINE; INSULIN; PAXILLIN;

ABDOMINAL FAT; AMINO ACID METABOLISM; APOPTOSIS; CELL ADHESION; DIET SUPPLEMENTATION; DIETARY INTAKE; GLUCONEOGENESIS; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; GLYCOGENOLYSIS; HORMONAL THERAPY; HYPERTROPHY; INSULIN RELEASE; INSULIN RESISTANCE; INTRACELLULAR TRANSPORT; MENOPAUSE; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OVARY FUNCTION; PANCREAS ISLET BETA CELL; REVIEW; WEIGHT GAIN;

ANIMALS; DIETARY SUPPLEMENTS; FEMALE; GLUCOSAMINE; GLUCOSE TRANSPORTER TYPE 4; INSULIN RESISTANCE; ISLETS OF LANGERHANS; POSTMENOPAUSE;

EID: 84860738731     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/gme.0b013e3182504111     Document Type: Review

References (25)

1. Furnsinn C, Sanderson AL, Radda GK Leighton B. Effects of glucosamine on insulin-stimulated glucose metabolism in rat soleus muscle. Int J Biochem Cell Biol 1995;27:805-814.
2. Balkan B, Dunning BE. Glucosamine inhibits glucokinase in vitro and produces glucose-specific impairment of in vivo insulin secretion in rats. Diabetes 1994;43:1173-1179.
3. Robinson KA, Sens DA, Buse MG. Pre-exposure to glucosamine induces insulin resistance of glucose transport and glycogen synthesis in isolated rat skeletal muscles. Study of mechanisms in muscle and in rat-1 fibroblats overexpressing the human insulin receptor. Diabetes 1993;42: 1333-1346.
4. Miles P, Higo K, Olefsky J. Exercise-stimulated glucose turnover in the rat is impaired by glucosamine infusion. Diabetes 2001;50:139-142.
5. Buse MG. Hexoamines, insulin resistance, and the complication of diabetes: current status. Am J Physiol Endocrinol Metab 2006;290:E1-E8.
6. Ciaraldi TP, Carter L, Nikoulina S, Mudaliar S, McClain DA, Henry RR. Glucosamine regulation of glucose metabolism in human skeletal muscle cells: divergent effects on glucose transport/phosphorylation and glycogen synthase in non-diabetic and type 2 diabetic subjects. Endocrinology 1999;140:3971-3980.
7. Baron AD, Zhu JS, Zhu JH, Weldon H, Maianu L, Garvey WT. Glucosamine induces insulin resistance in vivo by affecting GLUT 4 translocation in skeletal muscle: implications for glucose toxicity. J Clin Invest 1995;96:2792-2801.
8. Lafontaine-Lacasse M, Dore M, Pecard F. Hexosamines stimulate apoptosis by altering Sirt1 actions and levels in rodent pancreatic A-cells. J Endocrinol 2011;208:41-49.
9. Malaisse WJ, Lea MA, Malaisse-Lague F. The effect of mannoheptulose on the phosphorylation of glucose and the secretion of insulin by islet of Langerhans. Metabolism 1968;17:126-132.
10. Monauni T, Zenti MG, Cretti A, et al. Effects of glucosamine infusion on insulin secretion and insulin action in humans. Diabetes 2000;49: 926-935.
11. Kwak TK, Kim H, Jung O, et al. Glucosamine treatment-mediated O-GlcNAc modification of paxillin depends on adhesion state of rat insulinoma INS-1 cells. J Biol Chem 2010;285:36021-36031.
12. Tannis AJ, Barban J, Conquer JA. Effects of glucosamine supplementation on fasting and non-fasting plasma glucose and serum insulin concentrations in healthy individuals. Osteoarthritis Cartilage 2004;12: 506-511.
13. Pouwels MJ, Jacobs JR, Span PN, Lutterman JA, Smits P, Tack CJ. Short-term glucosamine infusion does not affect insuling sensitivity in humans. J Clin Endocrinol Metab 2001;86:2099-2103.
14. Dostrovsky NR, Towheed TE, Hudson RW, Anastassiades TP. The effects of glucosamine on glucose metabolism in humans: a systematic review of the literature. Osteoarthritis Cartilage 2011;19:375-380.
15. Maniyappa R, Karne RJ, Hall G, et al. Oral glucosamine for 6 weeks at standard doses does not cause or worsen insulin resistance or endothelial dysfunction in lean or obese subjects. Diabetes 2006;55:3142-3150.
16. Ogden CL, Yanovski SZ, Carroll MD, Flegal KM. The epidemiology of obesity. Gastroenterology 2007;132:2087-2102.
17. Brown LM, Gent L, Davis K, Clegg DJ. Metabolic impact of sex hormones on obesity. Brain Res 2010;1350:77-85.
18. Kang L, Chen CH, Cheng YC, et al. Glucosamine-induced insulin resistance in ovariectomized rats is relevant to decreasing the expression of glucose transport protein subtype 4 in skeletal muscle and in increasing the size of pancreatic islets. Menopause 2012;19:496-502.
19. Bryzgalova G, Lundholm L, Portwood N, et al. Mechanisms of antidiabetogenic and body weight-lowering effects of estrogen in high-fat diet-fed mice. Am J Physiol Endocrinol Metab 2008;295:E904-E912.
20. Riant E, Waget A, Cogo H, Arnal JF, Brucelin R, Gourdy P. Estrogens protect against high-fat diet-induced insulin resistance and glucose intolerance in mice. Endocrinology 2009;150:2109-2117.
21. Ahmed-Sorour H, Bailey CJ. Role of ovarian hormones in the long-term control of glucose homeostasis, glycogen formation and gluconeogenesis. Ann Nutr Metab 1981;25:208-212.
22. Alonso-Magdelena P, Ropero AB, Carrera MP, et al. Pancreatic insulin content regulation by the estrogen receptor. PLoS One 2008;3:e2069.
23. Le May C, Chu K, Hu M, et al. Estrogens protects pancreatic beta-cells from apoptosis and prevent insulin-deficient diabetes mellitus in mice. Proc Natl Acad Sci 2006;103:9232-9237.
24. Evans MJ, Eckert A, Lai K, Adelman SJ, Harnish DC. Reciptocal antagonism between estrogen receptor and NF-JB activity in vivo. Circ Res 2001;89:823-830.
25. Bussaard HE, Gevers Leuven JA, Frolich M, Kluft C, Krans HM. Shortterm oestrogen replacement therapy improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM. Diabetologia 1997;40:843-849.